Evaluation of the Effect of Nabiximols Oromucosal Spray on Clinical Measures of Spasticity in Participants With Multiple Sclerosis

NCT04984278 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

56

Enrollment

INDUSTRY

Sponsor class

Stopped The study was terminated based on a business decision by the Sponsor.

Conditions

Spasticity With Multiple Sclerosis

Interventions

DRUG: Nabiximols
DRUG: Placebo

Sponsor

Jazz Pharmaceuticals